Azerbaijan vs Singapore: Share of people with HIV who receive antiretroviral therapy
Azerbaijan
86.0%
in 2024
Singapore
86.0%
in 2023
Azerbaijan rank
33rd
Singapore rank
33rd
Share of people with HIV who receive antiretroviral therapy over time
- Azerbaijan
- Singapore
How they compare
Azerbaijan currently reports 86.0% against 86.0% in Singapore, a difference of 0.0%.
Across all 23 years both countries report, Singapore has been ahead every year.
Azerbaijan ranks 33rd and Singapore ranks 33rd of 143 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Azerbaijan | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 19.4% | 18.8% | Singapore |
| 2010s | 26.3% | 69.9% | 43.6% | Singapore |
| 2020s | 67.2% | 85.0% | 17.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Azerbaijan or Singapore?
- Azerbaijan, at 86.0% against 86.0% in Singapore as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Azerbaijan and Singapore?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Singapore?
- 23 years are reported by both, from 2000 to 2023.
- How do Azerbaijan and Singapore rank globally for share of people with hiv who receive antiretroviral therapy?
- Azerbaijan ranks 33rd and Singapore ranks 33rd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.